Sol-Gel - Bathi resik saben saham sajrone patang kuartal pungkasan SLGL

Sol-Gel Technologies (SLGL) generates revenue by licensing its innovative active component protection system for dermatology. Leveraging patents for silica microcapsules, the company maintains strong pricing power. The current profit figure stands at -360.30. This price chart illustrates a phase of product line expansion and the development of R&D projects aimed at securing new licensing fees.

Investors use this metric to evaluate the efficiency of profit scaling by analyzing the trend of net income per share over a rolling year. The calculation captures the percentage change in EPS (TTM), which for Sol-Gel Technologies (SLGL) reflects the stability of royalties from licensing agreements, while the GURU.Markets tool visualizes the resilience of this partnership model through a clear indicator of annual net income per share (TTM) growth.